To access this element change to forms mode OFF
Grant Award View - GA29848
Triple therapy prevention of Recurrent Intracerebral Disease EveNts...
GA ID:
GA29848
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2023
Value (AUD):
$1,416,383.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) – Cognitive sub-study
Purpose:
Extraordinarily high rates of dementia are evident in survivors of intracerebral haemorrhage (ICH), the most serious form of stroke. This project will determine in 400 subjects from the TRIDENT trial, whether over a 2-year period, the “triple pill’ for intense blood pressure lowering, can reduce memory and cognitive decline in comparison to standard care. A secondary aim will be to examine the key mediators of cognitive decline using brain scanning markers of small vessel disease.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1159055
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA